Aora Health Attended CPHI 2024

News

13 Dec 2024

Aora Health participated in CPHI 2024 in Milan, the world’s leading pharmaceutical event. This global event provided the perfect opportunity to showcase our innovative products and highlight our dedication to improving lives through science and innovation.

This year, Aora Health presented the three new C.I.C products; Lacta Duo; a long-term treatment for lactose intolerance, UcCol Duo, for ulcerative colitis and CycleFem Duo, for PMS and dysmenorrhea in women.

The excitement surrounding Aora Health’s portfolio was palpable, with attendees praising the high standards, strong clinical evidence, and relentless focus on research and development that define every product we bring to market Our commitment to innovation ensures that each solution we create is effective, safe, and tailored to meet the needs of diverse populations.

CPHI 2024 also offered an incredible platform to connect with our existing partners to exchange ideas, and to explore new collaborations that align with our mission to provide people with the very best in health and wellness. We are grateful for the enthusiastic reception and the meaningful conversations that reinforced the importance of our work.

Aora Health remains steadfast in its commitment to delivering cutting-edge solutions that elevate health outcomes globally. Here’s to shaping the future of healthcare, together!